The Journal of Organic Chemistry
Article
(m, 3H), 5.25 (q, J = 8.0 Hz, 20.0 Hz, 1H), 2.09 (d, J = 12.0 Hz). 13
NMR (75 MHz, CDCl3): δ 143.3, 128.7, 128.4, 126.8, 49.6, 26.9, 26.8.
MS-EI: m/z 105 (100%), 79 (25%), 77 (25%).
C
3-Bromoindan-1-one (Table 4, entry 17). Yield: 990 mg (94%). 1H
NMR (300 MHz, CDCl3): δ 7.77−7.71 (m, 3H), 7.54−7.46 (m, 1H),
5.61 (dd, J = 4.0 Hz, 8.0 Hz, 1H), 3.37 (dd, J = 8.0 Hz, 28.0 Hz, 1H),
3.06 (dd, J = 4.0 Hz, 28.0 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ
201.5, 154.3, 136.0, 135.6, 129.7, 127.5, 123.4, 48.1, 40.7, 40.7. MS-EI:
m/z 131 (100%), 103 (60%), 77 (40%).
2-Methylbenzyl Bromide (Table 4, entry 4). Yield: 647 mg (70%).
1H NMR (300 MHz, CDCl3): δ 7.30−7.18 (m, 4H), 4.55 (s, 2H),
2.45 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 137.3, 135.7, 130.8,
130.0, 129.0, 126.4, 32.4, 18.8. MS-EI: m/z 105 (100%), 103 (20%),
79 (22%), 77 (22%).
4-Chlorobenzyl Bromide (Table 4, entry 5). Yield: 894 mg (87%).
1H NMR (300 MHz, CDCl3): δ 7.34 (s, 4H), 4.48 (s, 2H). 13C NMR
(75 MHz, CDCl3): δ 136.3, 134.3, 130.4, 129.0, 32.5. MS-EI: m/z 127
(30%), 125 (100%), 89 (45%).
2-Chlorobenzyl Bromide (Table 4, entry 6). Yield: 905 mg (88%).
1H NMR (300 MHz, CDCl3): δ 7.48−7.40 (m, 2H), 7.31−7.26 (m,
2H), 4.62 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 135.4, 134.3, 131.3,
130.1, 130.0, 127.3, 30.6. MS-EI: m/z 127 (30%), 125 (100%), 89
(40%).
1-Bromo-1-phenylacetone (Table 4, entry 18). Yield: 992 mg
1
(93%). H NMR (300 MHz, CDCl3): δ 7.48−7.36 (m, 5H), 5.46 (s,
1H), 2.32 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 199.2, 135.1, 129.2,
129.1, 128.7, 56.4, 26.3. MS-EI: m/z 171 (30%), 169 (35%), 133
(90%), 118 (25%), 105 (35%), 90 (95%), 89 (100%).
2-(1′-Bromoethyl)pyridine (Table 4, entry 19). Yield: 860 mg
(92%). 1H NMR (300 MHz, CDCl3): δ 8.58 (d, J = 4.0 Hz, 1H), 7.70
(t, J = 12.0 Hz, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.21 (dd, J = 8.0 Hz,
12.0 Hz, 1H), 5.24 (q, J = 8.0 Hz, 1H), 2.08 (d, J = 12.0 Hz, 3H). 13C
NMR (75 MHz, CDCl3): δ 161.0, 149.3, 137.0, 123.0, 121.6, 49.4,
25.0, 25.0. MS-EI: m/z 105 (100%), 103 (20%), 79 (25%), 77 (25%).
4-Bromobenzyl Bromide (Table 4, entry 7). Yield: 975 mg (78%).
1H NMR (300 MHz, CDCl3): δ 7.49 (d, J = 12.0 Hz, 2H), 7.28 (d, J =
12.0 Hz, 2H), 4.46 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 136.81,
131.99, 130.71, 122.49, 32.46. MS-EI: m/z 171 (80%), 169 (90%), 90
(100%), 89 (75%).
ASSOCIATED CONTENT
■
S
* Supporting Information
Supporting tables and figures and copies of 1H NMR spectra of
all prepared compounds. This material is available free of
3-Bromobenzyl Bromide (Table 4, entry 8). Yield: 1025 mg (82%).
1H NMR (300 MHz, CDCl3): δ 7.57 (s, 1H), 7.45 (d, J = 8.0 Hz, 1H),
7.34 (d, J = 8.0 Hz, 1H), 7.23 (t, J = 8.0 Hz, 1H), 4.45 (s, 2H). 13C
NMR (75 MHz, CDCl3): δ 139.9, 132.1, 131.5, 130.3, 127.7, 122.6,
32.1. MS-EI: m/z 171 (80%), 169 (90%), 90 (100%), 89 (75%).
4-Iodobenzyl Bromide (Table 4, entry 9). Yield: 1175 mg (79%).
1H NMR (300 MHz, CDCl3): δ 7.70 (d, J = 12.0 Hz, 2H), 7.15 (d, J =
12.0 Hz, 2H), 4.44 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 138.0,
137.4, 130.9, 94.2, 32.5. MS-EI: m/z 217 (99%), 90 (100%), 89 (75%).
4-Nitrobenzyl Bromide (Table 4, entry 10). Yield: 927 mg (86%).
1H NMR (300 MHz, CDCl3): δ 8.22 (d, J = 12.0 Hz, 2H), 7.58 (d, J =
12.0 Hz, 2H). 5.54 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 147.7,
144.8, 129.9, 124.1, 31.0. MS-EI: m/z 136 (100%), 106 (20%), 90
(45%), 89 (60%), 78 (60%).
AUTHOR INFORMATION
Corresponding Authors
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by Eli Lilly and Company through the
Lilly Research Award Program (LRAP). We thank Dr. Scott A.
May for his contributions to this work.
4-(Bromomethyl)benzophenone (Table 4, entry 11). Yield: 1047
1
mg (76%). H NMR (300 MHz, CDCl3): δ 7.83−7.79 (m, 4H), 7.62
REFERENCES
■
(t, J = 8.0 Hz, 2H), 7.59−7.48 (m, 4H), 4.56 (s, 2H). 13C NMR (75
MHz, CDCl3): δ 196.0, 142.1, 137.5, 137.4, 132.6, 130.6, 130.0, 129.0,
128.4, 32.3. MS-EI: m/z 195 (90%), 167 (100%), 118 (20%), 105
(35%).
(1) Larock, R. C. Comprehensive Organic Transformations: A Guide to
Functional Group Preparations, 2nd ed.; Wiley-VCH: New York, 1999.
(2) (a) Wohl, A. Ber. Dtsch. Chem. Ges. 1919, 52, 51−63. (b) Ziegler,
K.; Spath, A.; Schaaf, E.; Schumann, W.; Winkelmann, E. Justus Liebigs
Ann. Chem. 1942, 551, 80−119.
4-(Bromomethyl)acetophenone (Table 4, entry 12). Yield: 825 mg
1
(77%). H NMR (300 MHz, CDCl3): δ 7.94 (d, J = 12.0 Hz, 2H),
(3) (a) Veisi, H.; Ghorbani-Vaghei, R.; Zolfigol, M. A. Org. Prep.
Proced. Int. 2011, 43, 489−540. (b) Djerassi, C. Chem. Rev. 1948, 43,
271−317.
7.50 (d, J = 12.0 Hz, 2H), 4.52 (s, 2H), 2.62 (s, 3H). 13C NMR (75
MHz, CDCl3): δ 197.4, 142.8, 136.9, 129.2, 128.8, 32.1, 26.9. MS-EI:
m/z 133 (100%), 118 (60%), 105 (70%), 90 (65%).
(4) For some recent examples, see: (a) Haberhauer, G.; Tepper, C.;
Ethyl 4-(Bromomethyl)benzoate (Table 4, entry 13). Yield: 995
mg (82%). 1H NMR (300 MHz, CDCl3): δ 8.03 (d, J = 12.0 Hz, 2H),
7.47 (d, J = 12.0 Hz, 2H), 4.52 (s, 2H), 4.39 (q, J = 8.0 Hz, 20.0 Hz,
2H), 1.41 (t, J = 8.0 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.04,
142.49, 130.41, 130.03, 128.98, 61.11, 32.29, 14.32. MS-EI: m/z 163
(100%), 135 (40%), 118 (35%), 107 (50%).
Wolper, C.; Blaser, D. Eur. J. Org. Chem. 2013, 2325−2333.
̈
̈
(b) Sreedharan, D. T.; Clive, D. L. J. Org. Biomol. Chem. 2013, 11,
3128−3144. (c) Pallela, V. R.; Mallireddigari, M. R.; Cosenza, S. C.;
Akula, B.; Subbaiah, D. R. C. V.; Reddy, E. P.; Reddy, M. V. R. Org.
Biomol. Chem. 2013, 11, 1964−1977. (d) Chen, J.; Sun, W.; Yang, J.;
Sun, H.; Wang, Z.; Dong, L.; Qiao, C.; Xi, C.-M. Bioorg. Med. Chem.
Lett. 2013, 23, 3785−3787. (e) Kadam, H. K.; Tilve, S. G. Eur. J. Org.
Chem. 2013, 4280−4284. (f) Ruchelman, A. L.; Man, H. W.; Zhang,
W.; Chen, R.; Capone, L.; Kang, J.; Parton, A.; Corral, L.; Schafer, P.
H.; Babusis, D.; Moghaddam, M. F.; Tang, Y.; Shirley, M. A.; Muller,
G. W. Bioorg. Med. Chem. Lett. 2013, 23, 360−365. (g) Belluti, F.;
Bartolini, M.; Bottegoni, G.; Bisi, A.; Cavalli, A.; Andrisano, V.; Rampa,
A. Eur. J. Med. Chem. 2011, 46, 1682−1693. (h) Lo Monte, F.;
Kramer, T.; Gu, J.; Brodrecht, M.; Pilakowski, J.; Fuertes, A.;
Dominguez, J. M.; Plotkin, B.; Eldar-Finkelman, H.; Schmidt, B. Eur.
J. Med. Chem. 2013, 61, 26−40. (i) Huang, J.; Xi, Z. Tetrahedron Lett.
2012, 53, 3654−3657. (j) Fu, L.; Liu, X.; Ling, C.; Cheng, J.; Guo, X.;
He, H.; Ding, S.; Yang, Y. Bioorg. Med. Chem. Lett. 2012, 22, 814−819.
(5) (a) Recknagel, R. O.; Glende, E. A.; Dolak, J. A.; Waller, R. L.
Pharmacol. Ther. 1989, 43, 139−154. (b) Rood, A. S.; McGavran, P.
D.; Aanenson, J. W.; Till, J. E. Risk Anal. 2001, 21, 675−695.
4-Cyanobenzyl Bromide (Table 4, entry 14). Yield: 785 mg (80%).
1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 12.0 Hz, 2H), 7.51 (d, J =
12.0 Hz, 2H), 4.49 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 142.8,
132.6, 129.7, 118.4, 112.2, 31.5. MS-EI: m/z 116 (100%), 89 (30%).
4′-Bromomethyl-2-cyanobiphenyl (Table 4, entry 15). Yield: 1240
1
mg (91%). H NMR (300 MHz, CDCl3): δ 7.79 (d, J = 8.0 Hz, 1H),
7.67 (t, J = 8.0 Hz, 1H), 7.59−7.45 (m, 6H), 4.57 (s, 2H). 13C NMR
(75 MHz, CDCl3): δ 144.7, 138.3, 138.2, 133.8, 133.0, 130.0, 129.5,
129.2, 127.8, 118.6, 111.2, 32.9. MS-EI: m/z 193 (15%), 192 (100%),
190 (15%), 165 (17%).
Methyl 4-(Bromomethyl)benzenesulfonate (Table 4, entry 16).
1
Yield: 929 mg (70%). H NMR (300 MHz, CDCl3): δ 7.89 (d, J =
12.0 Hz, 2H), 7.59 (d, J = 12.0 Hz, 2H), 4.52 (s, 2H), 3.78 (s, 3H).
13C NMR (75 MHz, CDCl3): δ 144.0, 135.0, 129.9, 128.5, 56.5, 31.3.
MS-EI: m/z 185 (100%), 121 (70%), 90 (72%), 89 (76%).
F
dx.doi.org/10.1021/jo402409k | J. Org. Chem. XXXX, XXX, XXX−XXX